November 2006

GENESIS Pharma S.A., one of the fastest growing Greek pharmaceutical companies, today announced that it has been listed No. 316 among the fastest growing European companies included in the 2006 Europe's 500 Listing, the annual ranking of high growth, job-creating companies published by Europe's 500 - Entrepreneurs for Growth and supported by Microsoft and KPMG.

Altogether, these 500 dynamic, entrepreneurial-driven winning companies have managed to sustain growth since 2002, boosting employment at an impressive average annual rate of 16% and sales at 18%. Despite the challenging business environment, these champions of growth have created nearly 150,000 jobs across Europe in three years. On average each company has created 99 new jobs per year and increased sales by 25 million euros per year. GENESIS Pharma S.A has increased employment by 64,8% and turnover by 290,2% during the years 2002-2005.

Awards will be presented to the winning companies in recognition of their performance and contribution to European economic welfare by European Commission Vice-President, Gunter Verheugen, in charge of Enterprise and Industry, at the Europe's 500 Awards Ceremony and Gala Dinner to be held on 25 November at the Hofburg in Vienna.

About Europe's 500
Europe's 500 was first published in 1996 and has been published on an annual basis ever since. During this time, more than 4.000 of Europe's high growth companies have received the accolade of being one of Europe's 500 champions of growth.
The Listing is intended to focus attention on entrepreneurial achievement and fast-growth European companies. Its focus on job creation and growth in medium sized enterprises is unique and distinguishes it from other business rankings.
Full information and the complete 2005 Europe's 500 Listing at: www.europes500.com/results.